24 Sep 2009 Genzyme’s Campath Meets Primary Endpoint in Phase 3 Combination Therapy Trial for Chronic Lymphocytic Leukemia
24 Sep 2009 Vectibix(R) in Combination With Chemotherapy Significantly Improves Progression-Free Survival in First-Line Metastatic Colorectal Cancer
24 Sep 2009 Farletuzumab Data Presented on Phase II Clinical Trial in First-Relapsed Ovarian Cancer Subjects
23 Sep 2009 Erbitux Significantly Increases Survival in 1st-Line Metastatic Colorectal Cancer Patients
23 Sep 2009 Initial COIN Study Results Presented at European Oncology Congress
23 Sep 2009 BioInvent updates on the progress of the Phase II trial of the long acting anticoagulant TB-402
23 Sep 2009 Roche announces results from two early studies which show promise for patients with malignant melanoma
23 Sep 2009 ImmunoCellular Therapeutics Announces Successful Humanization of Two Antibody Candidates
22 Sep 2009 Denosumab Demonstrates Superiority Over Zometa(R) in Delay of Complications Due to Bone Metastases in Advanced Breast Cancer Patients
22 Sep 2009 Vectibix(R) in Combination With Chemotherapy Significantly Improves Progression-Free Survival in Second-Line Metastatic Colorectal Cancer
21 Sep 2009 Micromet Reports Interim Data from Phase 1 Study of BiTE Antibody MT110 for the Treatment of Solid Tumors
21 Sep 2009 Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases
18 Sep 2009 Pancreatic and Colorectal Cancer Novel Antibody Developed from a Vaccine to Begin Phase I Trial
18 Sep 2009 ArmaGen completes primate safety study for AGT-181
17 Sep 2009 Alligator Bioscience enters into research and option agreement with BioInvent to jointly develop Antibody-based therapeutics for novel treatments for oncology indications
17 Sep 2009 Phase III Study Showed Patients Lived Longer Without Low-Grade Lymphoma Progressing When Rituxan Was Used First-Line for Maintenance
17 Sep 2009 ImmunoGen Announces Amgen has Licensed Rights to Use the Company's TAP Technology for a Solid Tumor Target
16 Sep 2009 Avaxia Biologics Awarded Phase I SBIR Grant to Develop Antibody Therapeutic for Oral Mucositis
15 Sep 2009 Kenta Biotech Reports Phase IIa Data with Lead Candidate Panobacumab in Hospital-Acquired Pneumonia
15 Sep 2009 Enrollment Completed in Regeneron and Bayer HealthCare Phase 3 Studies of VEGF Trap-Eye in Neovascular Age-Related Macular Degeneration (Wet AMD)
14 Sep 2009 Phase 3 Trial of Aflibercept in Metastatic Pancreatic Cancer Discontinued
11 Sep 2009 Genzyme’s Alemtuzumab for Multiple Sclerosis Shows Durable Treatment Benefit in Review of Four-Year Phase 2 Trial Data
09 Sep 2009 ImmunoCellular Therapeutics Enters into Research and License Option Agreement with Roche Group
09 Sep 2009 XOMA Announces $6 Million Antibody Discovery Collaboration With Arana Therapeutics
08 Sep 2009 MorphoSys Announces Clinical Milestone in Cancer Program with Bayer Schering Pharma

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up